Rritual Superfoods to raise up to $6M in CSE IPO
Rritual filed final prospectus in connection with its IPO on CSE and will 17,391,305 units at $0.30 per unit for gross proceeds of $5,217,391.50.Read More →
Rritual filed final prospectus in connection with its IPO on CSE and will 17,391,305 units at $0.30 per unit for gross proceeds of $5,217,391.50.Read More →
Triumvira Immunologics secured US $55M Series A funding from Leaps by Bayer, Northpond Ventures, Oceanpine Capital, Viva Biotech Holdings, Bloom Burton & Co., the Centre for Commercialization of Cancer Immunotherapy (C3i).Read More →
Canada Pension Plan Investment Board, Public Sector Pension Investment Board are among a group of investors backing Sana Biotechnology.Read More →
Biofourmis to acquire Zürich, Switzerland based Biovotion AG, a leading developer of a cutting-edge clinical-grade wearable biosensor platform.Read More →
Leo Resources Inc. Completes Acquisition of Green Life Clinics, Set to Begin Trading as Global Health Clinics Under Symbol “MJRX”Read More →
CANOPY GROWTH STRENGTHENS COMMITMENT TO CANNABIS-BASED MEDICINES THROUGH COMPLETION OF CANOPY HEALTH INNOVATIONS ACQUISITIONRead More →
Akumin Inc. (TSX: AKU.U) t to acquire a freestanding, fixed-site outpatient diagnostic imaging business located in Florida for US $27.5 million.Read More →
Akumin Inc. (TSX: AKU.U) completed bought deal offering of 8,750,000 common shares at US $4.00 for gross proceeds of US $35,000,000. Clarus Securities Inc. led the offering.Read More →
Akumin (TSX: AKU.U) engaged Clarus Securities Inc. for a bought deal of 8,750,000 Common Shares at US $4.00 for gross proceeds of US $35,000,000 Read More →
DiaMedica Therapeutics (TSX-V: DMA; OTCQB: DMCAF) closed second and final tranche of offering for gross proceeds of approximately US$2.5M. The company raised US $6.3M in two tranches.Read More →
Xenon Pharmaceuticals (NASDAQ: XENE) terminated collaborative development and license agreement with Teva Pharmaceuticals and closed share exchange transaction with Biotechnology Value Fund (BVF)Read More →
Profound Medical Corp. (TSX-V: PRN; OTCQX: PRFMF) closed previously announced bought for gross proceeds of $34.5M. Canaccord Genuity Corp. led the offeringRead More →
© 2023 CPE Newswire, a division of CPE Media & Data Company. All Rights Reserved. Logos are property of their respective owners. 500-245 Fairview Mall Drive, Toronto, ON M2J 4T1 | 647-872-6300